Vaxcyte Inc annual net income for fiscal TTM was -$1.1 billion, a decrease of 38.7% from -$767 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | ($1.1B) | ($767M) | ($464M) | ($402M) | ($223M) | ($100M) | ($89M) | ($50M) | ($29M) | ($17M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | ($284M) | ($321M) | ($247M) | ($213M) | ($167M) | ($141M) | ($137M) | ($103M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More PCVX metrics: Revenue · Gross Profit · Operating Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All PCVX financial statements → Interactive PCVX charts →
About TickerBase · Data methodology & sources · Privacy · Terms